Amanta Healthcare Limited (NSE:AMANTA)
164.13
+7.80 (4.99%)
At close: Aug 17, 2026
Amanta Healthcare Revenue
Amanta Healthcare had revenue of 688.03M INR in the quarter ending June 30, 2026, with 5.35% growth. This brings the company's revenue in the last twelve months to 2.91B, up 7.08% year-over-year. In the fiscal year ending March 31, 2026, Amanta Healthcare had annual revenue of 2.88B with 4.72% growth.
Revenue (ttm)
2.91B
Revenue Growth
+7.08%
P/S Ratio
1.94
Revenue / Employee
5.58M
Employees
522
Market Cap
5.64B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.88B | 129.69M | 4.72% |
| Mar 31, 2025 | 2.75B | -56.32M | -2.01% |
| Mar 31, 2024 | 2.80B | 212.11M | 8.19% |
| Mar 31, 2023 | 2.59B | 336.88M | 14.94% |
| Mar 31, 2022 | 2.25B | 541.47M | 31.61% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Anuh Pharma | 7.79B |
| Sudarshan Pharma Industries | 7.32B |
| Wanbury | 6.53B |
| Hexagon Nutrition | 4.15B |
| ZIM Laboratories | 3.97B |
| Albert David | 3.64B |
| Bharat Parenterals | 3.23B |
| Medico Remedies | 2.38B |